Highlights from the breakout session: advances in treatment II

被引:0
|
作者
Segelmark, Marten [1 ,2 ]
Diaz, Montserrat [3 ,4 ]
机构
[1] Lund Univ, Deptertment Clin Sci, Lund, Sweden
[2] Skane Univeristy Hosp, Dept Endocrinol Nephrol & Rheumatol, Lund, Sweden
[3] Dept Nephrol, Fundacio Puigvert, Dept Nephrol, Barcelona, Spain
[4] Autonoma Barcelona Univ, Barcelona, Spain
关键词
vasculitis; anti-neutrophil cytoplasm antibody; B cells; clinical trials and methods; immunosuppressants; wegener's granulomatosis; CYCLOPHOSPHAMIDE; RITUXIMAB;
D O I
10.1093/rheumatology/keae421
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:i115 / i116
页数:2
相关论文
共 50 条
  • [21] Report from breakout session 8
    Taylor, S
    DOCUMENT DELIVERY BEYOND 2000, 1999, : 187 - 188
  • [22] Report from breakout session 6
    Cornish, G
    DOCUMENT DELIVERY BEYOND 2000, 1999, : 184 - 185
  • [23] Workshop breakout session reports
    Roco, Mihail
    Thursby, Marie
    NANOTECHNOLOGY: SOCIETAL IMPLICATIONS I - MAXIMIZING BENEFITS FOR HUMANITY, 2007, : 53 - 119
  • [24] Breakout session 6: Chondroprogenitors
    Grande, DA
    Nixon, AJ
    CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2000, (379) : S222 - S224
  • [25] Breakout session: Transition to the market
    Perry, J
    Ewart, L
    Zhou, J
    INVESTING IN TEXAS: FINANCING HEALTH COVERAGE EXPANSION, CONFERENCE PROCEEDINGS, 2003, : 81 - 85
  • [26] Breakout session 7: Spine
    Kang, JD
    Boden, SD
    CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2000, (379) : S256 - S259
  • [27] Summary to breakout session F
    Hellman, K
    Vincent, C
    Honstead, J
    Rohwer, R
    DeLustro, F
    Detwiler, L
    Egan, M
    Foster, L
    Gill, P
    Kozak, P
    Robinson, M
    Wright, G
    Ziomek, C
    VIRAL SAFETY AND EVALUATION OF VIRAL CLEARANCE FROM BIOPHARMACEUTICAL PRODUCTS, 1996, 88 : 291 - 294
  • [28] Breakout session 10: Osteoarthritis
    McIlwraith, CW
    Frisbie, DD
    CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2000, (379) : S311 - S312
  • [29] Summary to breakout session G
    Stein, K
    Martin, P
    Bander, N
    Eck, S
    Hughes, J
    Morgan, E
    Schlesinger, H
    Wilson, C
    Weiner, G
    VIRAL SAFETY AND EVALUATION OF VIRAL CLEARANCE FROM BIOPHARMACEUTICAL PRODUCTS, 1996, 88 : 305 - 305
  • [30] Breakout session 2: Bone
    Goldstein, SA
    CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 1999, (367) : S133 - S134